LifeMD Profit Margin vs. Shares Outstanding

LFMD Stock  USD 5.57  0.04  0.71%   
Based on the measurements of profitability obtained from LifeMD's financial statements, LifeMD Inc may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess LifeMD's ability to earn profits and add value for shareholders.

LifeMD Net Profit Margin

(0.14)

At present, LifeMD's Operating Cash Flow Sales Ratio is projected to increase slightly based on the last few years of reporting. The current year's Days Of Sales Outstanding is expected to grow to 23.33, whereas EV To Sales is forecasted to decline to 1.66. The current year's Income Tax Expense is expected to grow to about 449.4 K, whereas Accumulated Other Comprehensive Income is forecasted to decline to (147.00).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.610.8761
Way Down
Pretty Stable
For LifeMD profitability analysis, we use financial ratios and fundamental drivers that measure the ability of LifeMD to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well LifeMD Inc utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between LifeMD's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of LifeMD Inc over time as well as its relative position and ranking within its peers.
  

LifeMD's Revenue Breakdown by Earning Segment

Check out Correlation Analysis.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LifeMD. If investors know LifeMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LifeMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.64)
Revenue Per Share
4.847
Quarterly Revenue Growth
0.383
Return On Assets
(0.21)
Return On Equity
(7.82)
The market value of LifeMD Inc is measured differently than its book value, which is the value of LifeMD that is recorded on the company's balance sheet. Investors also form their own opinion of LifeMD's value that differs from its market value or its book value, called intrinsic value, which is LifeMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LifeMD's market value can be influenced by many factors that don't directly affect LifeMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between LifeMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if LifeMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LifeMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

LifeMD Inc Shares Outstanding vs. Profit Margin Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining LifeMD's current stock value. Our valuation model uses many indicators to compare LifeMD value to that of its competitors to determine the firm's financial worth.
LifeMD Inc is rated below average in profit margin category among its peers. It is rated fourth overall in shares outstanding category among its peers . At present, LifeMD's Net Loss is projected to increase slightly based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value LifeMD by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

LifeMD Shares Outstanding vs. Profit Margin

Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.

LifeMD

Profit Margin

 = 

Net Income

Revenue

X

100

 = 
(0.12) %
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

LifeMD

Shares Outstanding

 = 

Public Shares

-

Repurchased

 = 
43.31 M
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.

LifeMD Shares Outstanding Comparison

LifeMD is currently under evaluation in shares outstanding category among its peers.

LifeMD Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in LifeMD, profitability is also one of the essential criteria for including it into their portfolios because, without profit, LifeMD will eventually generate negative long term returns. The profitability progress is the general direction of LifeMD's change in net profit over the period of time. It can combine multiple indicators of LifeMD, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income(140.00)(147.00)
Operating Income-14.5 M-15.2 M
Income Before Tax-17.4 M-18.3 M
Total Other Income Expense Net-2.9 M-2.8 M
Net Loss-20.6 M-21.6 M
Income Tax Expense428 K449.4 K
Net Loss-43.8 M-41.6 M
Net Interest Income-2.8 M-2.7 M
Net Loss-26.2 M-27.5 M
Non Operating Income Net Other-3.6 M-3.8 M
Change To Netincome20.6 M11.3 M
Net Loss(0.61)(0.64)
Income Quality(0.43)(0.41)
Net Income Per E B T 1.18  0.74 

LifeMD Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on LifeMD. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of LifeMD position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the LifeMD's important profitability drivers and their relationship over time.

Learn to be your own money manager

Our tools can tell you how much better you can do entering a position in LifeMD without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Competition Analyzer Now

   

Competition Analyzer

Analyze and compare many basic indicators for a group of related or unrelated entities
All  Next Launch Module

Use Investing Themes to Complement your LifeMD position

In addition to having LifeMD in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Advertising Thematic Idea Now

Advertising
Advertising Theme
Companies specializing in advertising, marketing and advertising services. The Advertising theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Advertising Theme or any other thematic opportunities.
View All  Next Launch
When determining whether LifeMD Inc is a strong investment it is important to analyze LifeMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact LifeMD's future performance. For an informed investment choice regarding LifeMD Stock, refer to the following important reports:
Check out Correlation Analysis.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
To fully project LifeMD's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of LifeMD Inc at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include LifeMD's income statement, its balance sheet, and the statement of cash flows.
Potential LifeMD investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although LifeMD investors may work on each financial statement separately, they are all related. The changes in LifeMD's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on LifeMD's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.